Jiangsu Hualan Stock Hits Day Low of CNY 112.59 Amid Price Pressure

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. experienced a significant decline today, with its stock price dropping by 8.73% to reach an intraday low of CNY 112.59. This performance stands in contrast to the China Shanghai Composite, which saw a modest gain of 0.43% on the same day. Over the past week, Jiangsu Hualan's stock has decreased by 9.87%, while its performance over the last month shows a notable increase of 35.85%. However, the company has faced challenges in the longer term, with a concerning annual net sales growth rate of -2.11% and a steep decline in operating profit of 37.25% over the past five years. Despite a remarkable one-year performance of 283.09%, the company has reported negative results for the last seven consecutive quarters, indicating ongoing financial difficulties. Key metrics such as a low return on capital employed (ROCE) of 9.64% and a return on equity (ROE) of just 1.90% further highlight the company's struggles in generating profitability. With a market capitalization of CNY 16,086 million, Jiangsu Hualan continues to navigate a challenging financial landscape.